✨ Free AI Report
Zeria Pharmaceutical Co., Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Zeria Pharmaceutical Co., Ltd.
Company Research

Zeria Pharmaceutical Co., Ltd.: Business Overview, Financials & Competitive Analysis

Zeria Pharmaceutical Co., Ltd. scores 6/10 on the AskCyborg Cyborg Score (Solid). Established Japanese pharma leader with focused GI portfolio and growing international footprint representing solid value in underexposed niche market. Zeria demonstrates solid fundamentals as a established mid-cap pharmaceutical player with strong positioning in gastroenterology and meaningful international presence through subsidiaries. Revenue growth of 15.3% YoY and net income.

What is Zeria Pharmaceutical Co., Ltd.'s industry? Zeria Pharmaceutical Co., Ltd. (zeria.co.jp) operates in Pharmaceuticals & Healthcare. AskCyborg classifies Zeria Pharmaceutical Co., Ltd. under Pharmaceuticals & Healthcare in its company registry.

Zeria Pharmaceutical, founded in 1955 and based in Tokyo, Japan, focuses on R&D, manufacturing and sales of prescription drugs as well as OTC products. The company holds a leading position in Japan's gastroenterology ...

6/ 10Solid

Cyborg Score thesis

Established Japanese pharma leader with focused GI portfolio and growing international footprint representing solid value in...

Read the full analyst-debate transcript →
Industry Pharmaceuticals & Healthcare
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Zeria Pharmaceutical Co., Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Zeria Pharmaceutical Co., Ltd.

AskCyborg analysts argue the bull and bear cases for Zeria Pharmaceutical Co., Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Zeria Pharmaceutical Co., Ltd. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Zeria Pharmaceutical Co., Ltd. Overview

Pro stress-test →

Zeria Pharmaceutical, founded in 1955 and based in Tokyo, Japan, focuses on R&D, manufacturing and sales of prescription drugs as well as OTC products. The company holds a leading position in Japan's gastroenterology sector.

Strategic Profile

Pro stress-test →

The company is mainly engaged in the development of ethical drug business, consumer healthcare business and other business. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, manufacturing and selling pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark.

Competitive Landscape

Pro stress-test →

Zeria operates in Japan's competitive pharmaceutical market against major players like KYORIN Pharmaceutical and Mochida Pharmaceutical. The company differentiates through specialized focus on gastroenterology and a diversified consumer healthcare product portfolio. Its international footprint via Tillotts Pharma provides exposure beyond Japan's domestic market.

Industry Context

Zeria Pharmaceutical Co., Ltd. operates in Pharmaceuticals & Healthcare.

Key facts

Founded: 1955 · Headquarters: Tokyo, Japan · Employees: 1,746 · Revenue: $604.2M · Market cap: $686.1M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Zeria Pharmaceutical Co., Ltd..

  • Leading position in Japanese gastroenterology pharmaceutical market with specialized product portfolio
  • International expansion through acquisitions: Acquired Tillotts Pharma AG (Switzerland) in 2009 with operations across 10+ countries
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Trading at 2,451 JPY with market cap of ~107.33B JPY (~$686.1M USD)
  • Q3 FY2025Consolidated financial summary available showing operational progress
  • +1 moreTrack every material event for Zeria Pharmaceutical Co., Ltd. as it happens. Explore monitoring →
Get alerted when Zeria Pharmaceutical Co., Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Ethical Pharmaceuticals & Consumer Healthcare ProductsMajor Japanese pharmaceutical competitor→Prescription & OTC PharmaceuticalsDomestic pharmaceutical competitor→Gastroenterology & Specialty PharmaInternational pharma operations acquired 2009→

Compare Zeria Pharmaceutical Co., Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Zeria Pharmaceutical Co., Ltd. operates in Pharmaceuticals & Healthcare. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals & Healthcare research →
NEW · MCP server

Ask your AI assistant about Zeria Pharmaceutical Co., Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Zeria Pharmaceutical Co., Ltd. and its top competitor on Cyborg Score”
“What did Zeria Pharmaceutical Co., Ltd. do this quarter?”
“Is Zeria Pharmaceutical Co., Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Zeria Pharmaceutical Co., Ltd. do?+
Zeria Pharmaceutical, founded in 1955 and based in Tokyo, Japan, focuses on R&D, manufacturing and sales of prescription drugs as well as OTC products. The company holds a leading position in Japan's gastroenterology ...
What is Zeria Pharmaceutical Co., Ltd.'s Cyborg Score?+
Zeria Pharmaceutical Co., Ltd. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Zeria Pharmaceutical Co., Ltd.'s main competitors?+
Named competitors include Ethical Pharmaceuticals & Consumer Healthcare Products, Prescription & OTC Pharmaceuticals, Gastroenterology & Specialty Pharma. The full competitive landscape is in the AskCyborg report.
How can I get the full Zeria Pharmaceutical Co., Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Zeria Pharmaceutical Co., Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Zeria Pharmaceutical Co., Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals & Healthcare research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Natco Pharma Limited7Shenzhen Salubris Pharmaceuticals Co., Ltd.6Ono Pharmaceutical Co., Ltd.